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Abstract
Background: Considerable variation exists in the protocols used to induce hyperresponsiveness
in murine models of allergic sensitisation. We examined the effect of varying the number of antigen
exposures at challenge on the development of methacholine responsiveness in systemically
sensitised mice.
Methods: BALB/c mice were sensitised with ovalbumin (OVA), challenged with 1, 3 or 6 OVA
aerosols. Lung function was measured using low frequency forced oscillations and partitioned into
components representing the airways (Raw) and lung parenchyma (tissue damping (G) and tissue
elastance (H)). Responsiveness to inhaled methacholine (MCh), inflammatory cell profile and
circulating IgE were assessed 24 and 48 hours after challenge. The threshold dose of MCh required
to elicit a detectable response (sensitivity) and response to 30 mg.mL-1 (maximal response) were
determined for each compartment.
Results: Sensitivity; All three OVA protocols resulted in an increased sensitivity to MCh in Raw but
not in G or H. These responses where present at 24 and 48 hrs, except 1 OVA aerosol in which
changes had resolved by 48 hrs. Maximal response; 1 OVA aerosol increased maximal responses in
Raw, G and H at 24 hrs, which was gone by 48 hrs. Three OVA aerosols increased responses in H
at 48 hrs only. Six OVA challenges caused increases in Raw, G and H at both 24 and 48 hrs.
Eosinophils increased with increasing antigen challenges. IgE was elevated by OVA sensitisation but
not boosted by OVA aerosol challenge.
Conclusions: The pattern of eosinophilia, IgE and MCh responsiveness in mice was determined
by antigen dose at challenge. In this study, increased sensitivity to MCh was confined to the airways
whereas increases in maximal responses occurred in both the airway and parenchymal
compartments. The presence of eosinophilia and IgE did not always coincide with increased
responsiveness to inhaled MCh. These findings require further systematic study to determine
whether different mechanisms underlie airway and parenchymal hyperresponsiveness post antigen
challenge.
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Background
Persistent asthma is an allergic disease characterised by
airway inflammation ([1-5]) and hyperresponsiveness to
external stimuli ([1]). Mouse models of allergic airway
sensitisation are often used to elucidate the pathobiology
of this disease ([6-8]).
To date, a number of techniques have been used to meas-
ure changes in lung function in response to bronchocon-
stricting agents in murine models of allergic
bronchopulmonary inflammation (see [6,8,9] for
reviews). One method that has gained recent popularity is
unrestrained barometric plethysmography, which uses a
'pseudo-flow' measurement to derive a dimensionless
parameter known as enhanced pause (Penh). There are
now several publications in the literature which claim to
have documented airway hyperresponsiveness in aller-
gen-driven murine models based on methacholine
induced changes in Penh. However, it has also been well
documented that Penh does not correlate with changes in
the physiology of the lung ([10-14]), especially in chronic
disease states ([15]). In contrast, the low frequency forced
oscillation technique (LFOT) is able to provide sensitive
measurements of respiratory system input impedance
(Zrs) in the mouse, that are partitioned into components
representing airway and parenchymal compartments by
fitting the constant-phase model ([16-18]). Using LFOT,
Tomioka et al. ([17]) found that systemic sensitisation fol-
lowed by three antigen challenges, one of the most com-
mon allergen models utilised in studies using Penh,
resulted in hyperresponsiveness that was confined prima-
rily to the tissue compartment of the lung. This has impor-
tant implications for the interpretation of results obtained
with Penh that have demonstrated mechanisms underly-
ing allergic inflammation in mice given that a significant
portion of the respiratory system hyperreactivity to MCh
in human asthmatics is a result of the response of the con-
ducting airways ([19]).
One of the most common methods for inducing allergic
bronchopulmonary inflammation in mice involves sys-
temic sensitisation with a specific antigen and Th-2 skew-
ing adjuvant, usually ovalbumin (OVA) adsorbed onto
aluminium hydroxide (Alum), followed by airway chal-
lenge with the same antigen ([20-22]). However, consid-
erable variations exist between studies in terms of the dose
of antigen used during airway challenge. To date, a
number of studies have found that airway hyperrespon-
siveness is increased by increasing the dose of antigen at
challenge ([23-25]). However, these studies, which used
different doses of antigen at challenge as part of a broader
intervention protocol, have used Penh ([23,24]) or a
measure of total lung resistance ([25]) to examine the
resulting changes in lung physiology. As yet, no studies
have systematically examined the effect of the dose of
antigen at challenge on the subsequent development of
hyperresponsiveness using a technique that is able to par-
tition the reactivity of the lungs into airways and tissue
compartments.
Hyperresponsiveness of the respiratory system to bron-
choconstricting agents, and other outcome parameters
such as those that reflect inflammation and allergic sensi-
tisation, are often measured at different times post chal-
lenge. In an examination of the kinetics of
hyperresponsiveness in an OVA model of allergic sensiti-
sation in mice using a single dose of antigen at challenge,
Tomkinson  et al. ([26]) found that responsiveness to
methacholine (MCh) is maximal 24 hours post challenge,
has begun to resolve by 48 hours, and has returned to
baseline levels beyond that time. The kinetics of respon-
siveness to MCh in other studies, however, are often over-
looked and it is yet be determined if altering the dose of
antigen at challenge has an influence on the timing of
peak responsiveness to bronchoconstricting agents.
The aim of this study was to systemically investigate the
effect of antigen dose at challenge on the pattern of hyper-
responsiveness to inhaled MCh in a murine model of
allergic bronchopulmonary inflammation.
Methods
Animals
8 week old specific pathogen free female BALB/c mice
were purchased from the Animal Resources Centre, Mur-
doch, Western Australia. Mice were housed in a controlled
environment with a 12 hr light:dark cycle and provided
with an OVA free diet and acidified water ad libitum. All
experiments were approved by the Institutional Animal
Ethics and Experimentation Committee.
Sensitisation protocols
Mice were sensitised by intraperitoneal (i.p.) injection
with 20 µg of OVA (Sigma, St Louis, USA) suspended in
200 µL of Alum (Alu-gel-S, Serva, Heidelberg, Germany)
on days 0 and 14. Mice were then challenged with either
1, 3 or 6 OVA (1% w/v in PBS) aerosols delivered with an
ultrasonic nebuliser (UltraNeb®, DeVilbiss, Somerset,
Pennsylvania) for 30 minutes on consecutive days starting
at day 21 (Fig 1). Two additional groups of mice served as
controls; a naïve group and a group sensitised with i.p.
OVA and challenged with a single PBS aerosol using the
protocol described above.
Respiratory mechanics
Changes in Zrs were measured using a modification of the
low frequency forced-oscillation technique (LFOT) as
described previously ([27]). Briefly, mice were anaesthe-
tised with an i.p. injection of a solution containing xyla-
zine (2 mg.mL-1, Troy Laboratories, NSW, Australia) andRespiratory Research 2004, 5:15 http://respiratory-research.com/content/5/1/15
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ketamine (40 mg.mL-1, Troy Laboratories, NSW, Aus-
tralia) at a dose of 0.01 mL.g-1. Mice were tracheostomised
with a 10 mm section of polyethylene tubing (1.27 mm
OD: 0.86 mm ID) and ventilated (flexiVent, Scireq, Mon-
treal, Canada) at 450 b.min-1 with a tidal volume of 8
mL.kg-1 and a positive end expiratory pressure (PEEP) of 2
cmH2O. The lung volume history of the mice was stand-
ardised prior to measurement of lung mechanics using
two deep inflations and three P-V curves. The respiratory
system input impedance (Zrs) was measured during peri-
ods of apnea using a 16 s signal containing 19 mutually
prime sinusoidal frequencies ranging from 0.25 to 19.625
Hz. The constant phase model ([16]) was then fit to the
real and imaginary parts of the Zrs spectrum allowing the
calculation of airway resistance (Raw), tissue damping (G),
tissue elastance (H) and hysteresivity (η) ([28]).
Methacholine responsiveness
Changes in respiratory mechanics following inhaled MCh
were measured either 24 or 48 hrs after the last OVA aer-
osol. Following measurement of baseline Zrs, mice were
exposed to a 90 s saline aerosol delivered with an ultra-
sonic nebuliser (UltraNeb®, Devilbiss, Somerset, Pennsyl-
vania). Zrs was then measured every minute for the next 5
minutes. This aerosol procedure was repeated with 1/2
log10 incremental doses of MCh from 0.1 to 30 mg.mL-1
with Zrs measured every minute for at least 5 minutes
after the aerosol until the parameters calculated from the
constant phase model had peaked.
Inflammatory cell counts
Separate groups of mice, sensitised using the same proto-
col described above, were anaesthetised and tracheos-
tomised 24 or 48 hrs after their last aerosol. BAL fluid was
collected by slowly infusing and withdrawing a 1 mL aliq-
uot of PBS containing BSA (bovine serum albumin, 20
mg.mL-1, CSL, Victoria, Australia) and lidocaine (35
mg.mL-1, Sigma, St Louis, USA) from the lungs three
times. The BAL was then centrifuged at 2000 rpm for 4
mins. The supernatant was removed and the pellet resus-
pended in PBS. The cells were stained with trypan blue to
determine viability and the total cell count (TCC)
obtained by counting the cells with a haemocytometer.
Differential counts were obtained from the cytospin sam-
ple, stained with Leishman's stain and examined using
light microscopy. Three hundred cells were counted from
each sample to determine the relative proportions of each
cell type.
Serum IgE
In a separate group of mice, serum samples were periodi-
cally collected for analysis of total IgE. An additional con-
trol group was included in the analysis of serum IgE
consisting of mice sensitised with PBS/Alum. Sera were
diluted 1:7.5 in Delfia Assay buffer (Wallac Oy, Turku,
Finland). The diluted sera were analysed for the presence
of total IgE by time-resolved fluorescence (TRF) assays.
Briefly, 96-well plates (Nunc Maxisorp, Denmark) were
coated overnight at 4° C with anti-mouse IgE (R35-72; BD
PharMingen, San Diego, USA). Plates were blocked with
200 µl of 0.5% BSA in TRIS-HCl pH 7.4 for 1 hour at room
temperature on a plate shaker. For all subsequent steps a
volume of 50 µl per well was used and incubations were
performed for 1 hour at room temperature unless other-
wise indicated. Between steps, plates were washed five
times with wash buffer (TRIS-HCl pH 7.8 Tween20).
Mouse anti-TNP IgE (BD PharMingen, San Diego, USA)
was used as an interassay standard. Biotinylated anti-
mouse IgE (R35-118; BD PharMingen, San Diego, USA)
was added to the wells at 2 µg.mL-1. Straptavidin-conju-
gated Europium (Wallac Oy, Turku, Finland) was incu-
bated at 1:500 for 30 minutes and plates washed eight
times thereafter. Delfia enhancement solution (Wallac
Oy, Turku, Finland) was added and the plates were agi-
tated on a shaker for 10 minutes prior to reading the fluo-
rescence on a Wallac Victor 2 counter (Wallac Oy, Turku,
Finland). The detection limit of this assay is approxi-
mately 100 ng.mL-1.
Timeline for sensitisation and data collection Figure 1
Timeline for sensitisation and data collection. Time-
line for the protocols used to induce allergic bronchopulmo-
nary inflammation and timing for bronchoalveolar lavage 
(BAL), serum IgE measurement and assessment of hyperre-
sponsiveness to inhaled methacholine (MCh). Mice were sys-
temically sensitised with two intraperitoneal injections of 
OVA/Alum on day 0 and 14, challenged with either 1 (A), 3 
(B) or 6 (C) OVA aerosols (1%) for 30 minutes starting at 
day 21.
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Statistical analysis
Log10 transformed inflammatory cell and immunoglobu-
lin data were compared using ANOVA and Tukey's post-
hoc test. Responses in Raw and G to inhaled MCh at the
maximum dose used (30 mg.mL-1) were expressed as a
percentage of the response to the saline aerosol and com-
pared using non-parametric ANOVA on ranks and Dunn's
post-hoc test. Responses in H were expressed as a percent-
age of the response to saline, log10 transformed and com-
pared using ANOVA and Tukey's post-hoc test. The
threshold dose of MCh where there was a detectable
change in Raw, G or H (termed sensitivity hereafter) was
interpolated from the raw dose response curve as the
upper limit of the 99% CI of the 5 measurements taken
following the saline aerosol (Fig. 2). The sensitivity data
were compared using ANOVA and Tukey's post-hoc test.
All data were analysed using SigmaStat 2.03 and p values
< 0.05 were deemed to be significant.
Results
Methacholine responsiveness
The degree and time of observed maximum MCh induced
responses in Raw, G and H varied substantially between
treatments (Fig. 3). A summary of statistical comparisons
of sensitivity to MCh and percentage response to the max-
imum dose (30 mg.mL-1) between treatment groups and
naïve mice is presented in Table 1. Sensitisation followed
by challenge with a single PBS aerosol did not cause an
increase in sensitivity or maximum responsiveness to
MCh compared to naïve mice.
One OVA aerosol
A single OVA aerosol was sufficient to induce a significant
increase in MCh responsiveness in the airways, seen as
both a lower threshold dose of MCh required to induce a
response (increased sensitivity) and increased response at
the 24 hour time point (Table 1). In the parenchymal
compartment, no increase in sensitivity was seen but a sig-
nificant increase in maximal response was seen for both G
and H. This heightened sensitivity and response had
diminished, back to the level seen in naive mice, 48 hours
after the OVA aerosol.
Three OVA aerosols
Three OVA aerosols resulted in significantly increased air-
way (but not parenchymal) sensitivity to MCh at both the
24 and 48 hour time points (Table 1). However, there was
no increase in maximum response at 24 hours in Raw, G or
H and only an increased response in H after 48 hours but
not Raw and G.
Six OVA aerosols
Six OVA aerosols resulted in both significantly increased
airway sensitivity and maximal responses to MCh at 24
and 48 hours post-challenge. Increased maximal
responses, but not increased sensitivity, were also seen in
the parenchymal compartment at both the 24 and 48
hour time points.
Inflammatory cell counts
Challenge with a single PBS aerosol following systemic
sensitisation with OVA did not cause a significant increase
in TCC in the BAL (p = 0.552) compared to naïve mice
(Fig. 4). There was, however, a significant increase in TCC
in mice challenged with a single OVA aerosol (p = 0.032)
and a further increase in TCC following 3 OVA challenges
(p < 0.001). Exposure to 6 OVA aerosols did not cause any
further increase in TCC above levels observed in mice
exposed to 3 OVA aerosols (p = 0.805) but remained sig-
nificantly higher than mice challenged with 1 OVA aero-
sol (p < 0.001). Time of sampling after the last aerosol
with any of the protocols did not have a significant impact
on TCC (p = 0.357).
The number of aeroallergen challenges also had a signifi-
cant impact on the number of eosinophils (p < 0.001) and
macrophages (p < 0.001) in the BAL. There were signifi-
cant increases in the number of eosinophils in sensitised
mice challenged with 1 (p = 0.032), 3 (p < 0.001) and 6
(p < 0.001) OVA aerosols (Fig. 5) compared to naïve mice.
The numbers of eosinophils in the BAL of mice exposed to
3 and 6 aerosols were significantly higher than those
exposed to a single OVA aerosol (p < 0.001 and p < 0.001
respectively) but were not significantly different from
each other (p = 0.805). The number of macrophages in
the BAL were also higher in mice exposed to 3 (p < 0.001)
Technique for sensitivity calculation Figure 2
Technique for sensitivity calculation. Schematic repre-
sentation of the technique used for calculation of the thresh-
old dose of MCh (sensitivity) required to induce a detectable 
increase in Raw, G and H.
Saline
{ 99% CI
Threshold
dose
(Sensitivity)
MCh dose
ResponseRespiratory Research 2004, 5:15 http://respiratory-research.com/content/5/1/15
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Dose response curves to inhaled methacholine Figure 3
Dose response curves to inhaled methacholine. Dose response curves (expressed as a % of the response to saline aero-
sol) for mice systemically sensitised with OVA/Alum and challenged via the airways with 1 (left), 3 (centre) or 6 (right) OVA 
aerosols. Mice were challenged 24 (● ) or 48 (▲ ) hours after the last OVA aerosol. Dose response curves from naïve mice (❍ ) 
are also shown. All data are expressed as mean ± SEM (n = 7–8). * indicates significance (p < 0.05 vs naïve mice; ANOVA on 
Ranks, Dunn's post-hoc for Raw and G; ANOVA, Tukey's post-hoc for H).Respiratory Research 2004, 5:15 http://respiratory-research.com/content/5/1/15
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and 6 (p < 0.001) OVA aerosols compared to naïve mice.
As with TCC, time of sampling after the last aerosol did
not have a significant impact on the number of eosi-
nophils (p = 0.357) or macrophages (p = 0.079) in the
BAL. Low levels of neutrophils were observed in BALs
from OVA challenged mice sampled at 24 hours but not
in mice sampled 48 hours after the last OVA aerosol (Fig.
5). Lymphocyte numbers were not significantly elevated
in the BALs from any of the treatment groups (data not
shown).
Serum IgE
Total serum IgE was significantly increased at day 21 (p <
0.001), 7 days after the second injection of OVA/Alum,
compared to naïve mice (Fig. 6). In contrast, serum IgE
levels at day 14, after a single injection, were not signifi-
cantly elevated (p = 0.438) compared to naïve mice. The
total serum IgE response to systemic sensitisation, in the
absence of subsequent antigen aerosol challenge, peaked
at day 22 and partially declined by day 27. However, this
decrease was not statistically significant (p = 0.511). There
was no further increase in the total serum IgE in mice that
were sensitised and subsequently challenged with OVA
aerosols compared to those that were only systemically
sensitised (p = 0.842). Total serum IgE levels were not
significantly greater in mice sensitised with PBS/Alum and
challenged with OVA (data not shown).
Discussion
Varying the number of aeroallergen challenges in a sys-
temically sensitised murine model of allergic bronchopul-
monary inflammation altered the degree and timing of
hyperresponsiveness to inhaled MCh. A single OVA
Table 1: Summary of sensitivity and maximum responses to methacholine in airway and parenchymal lung compartments. Summary 
of the threshold dose (sensitivity) required to elicit a detectable increase in airway resistance (Raw), tissue damping (G) and tissue 
elastance (H) for naïve mice, mice systemically sensitised with OVA/Alum and challenged with PBS and mice systemically sensitised 
and challenged with OVA. Also shown is the percentage change in Raw, G and H in response to the maximum does of methacholine used 
(30 mg.mL-1). Data are presented as the mean (SEM).
Challenge Assessed after last 
aerosol (hr)
Sensitivity - Threshold dose of MCh (mg.mL-1) Response at 30 mg.mL-1 MCh
Raw G H Raw§ G§ H§
p* p* p* p* p* p*
Naïve - 0.54(0.14) - 0.51(0.25) - 0.10(0.02) - 235.5(21.5) - 138.8(6.1) - 145.4(5.1) -
1 PBS aerosol 24 and 48 pooled 0.55(0.30) ns 0.25(0.10) ns 0.06(0.01) ns 242.9(19.1) ns 141.5(4.7) ns 143.4(2.7) ns
1 OVA aerosol 24 0.09(0.03) 0.012 0.15(0.04) ns 0.05(0.01) ns 514.0(82.7) <0.05 275.5(30.6) <0.001 250.2(24.5) <0.001
48 0.46(0.19) ns 0.18(0.05) ns 0.17(0.07) ns 326.4(32.6) ns 213.0(14.6) ns 179.3(12.6) ns
3 OVA aerosols 24 0.12(0.03) 0.012 0.35(0.20) ns 0.06(0.01) ns 271.2(43.1) ns 180.3(41.7) ns 178.9(39.9) ns
48 0.20(0.07) 0.034 0.16(0.04) ns 0.08(0.01) ns 348.8(46.0) ns 243.6(42.7) ns 233.0(31.6) 0.045
6 OVA aerosols 24 0.17(0.05) 0.019 0.12(0.05) ns 0.06(0.01) ns 456.7(43.4) <0.05 358.2(88.4) <0.05 298.5(52.2) 0.02
48 0.16(0.05) 0.034 0.15(0.06) ns 0.06(0.01) ns 396.0(23.3) <0.05 304.8(28.5) <0.05 295.6(30.6) 0.018
§ expressed as a % of saline response
* vs naïve values
Total cell counts from bronchoalveolar lavage Figure 4
Total cell counts from bronchoalveolar lavage. Total 
cell counts (TCC) from the bronchoalveolar lavage (BAL) of 
naïve BALB/c mice, mice systemically sensitised and challenge 
with OVA aerosols and mice systemically sensitised with 
OVA and challenged with PBS. Samples were collected 24 
(grey) and 48 (black) hours after the last aerosol. Data are 
expressed as mean ± SEM (n = 5–6). Exposure to a PBS aer-
osol following antigen sensitisation did not cause an increase 
in TCC (p = 0.552). In contrast, a single OVA aerosol was 
sufficient to cause a significant increase in TCC (p = 0.032). 
Exposure to 3 OVA aerosols caused a further increase in 
TCC (p < 0.001) but 6 OVA aerosols did not cause an 
increase in TCC beyond those observed in mice exposed to 
3 OVA aerosols (p = 0.805).Respiratory Research 2004, 5:15 http://respiratory-research.com/content/5/1/15
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challenge increased airway sensitivity to inhaled MCh 24
hours after the challenge, while sensitivity remained ele-
vated for 48 hours after three and six challenges. OVA
challenge did not increase parenchymal sensitivity at any
level. In contrast to sensitivity measurements, the maxi-
mum response to 30 mg.mL-1 MCh showed a variable pat-
tern. A transient response was observed in both airway
and parenchymal compartments after a single OVA
aerosol. After 3 OVA aerosols significant increases were
seen in the tissue compartment at 48 hours, while after 6
OVA aerosols an elevated response was seen in the airway
and parenchymal compartments that persisted beyond 48
hours. There was a significant influx of inflammatory cells
in the BAL in response to OVA aerosols, however, the pres-
ence of this inflammation did not always result in hyper-
essponsiveness to inhaled MCh.
Murine models using 2 systemic allergen sensitisations
followed by 3 aeroallergen challenges are prevalent in the
literature ([20,29-31]) and have been reported to demon-
strate airway hyperresponsiveness to MCh. However,
these studies have used enhanced pause (Penh), which is
derived from unrestrained barometric plethysmography,
to measure changes in lung physiology. As Penh cannot
differentiate between constriction in the airways and
changes in the tissue compartment of the lungs, it is
impossible to tell where the responses to MCh are
localised, if indeed they are true physiological responses
([10-14]). In contrast, our study, using 2 systemic sensiti-
sations and 1,3 or 6 challenges, has demonstrated clear
airway, tissue or mixed compartment responses to metha-
choline which is dependent on the number of aerosol
challenges delivered. In our hands, the more common
model of 2 systemic sensitisations followed by 3 OVA
challenges resulted in increased responsiveness to the
maximum dose of MCh that was confined to the tissue
compartment of the lung. This finding is consistent with a
previous study by Tomioka et al. ([17]), which also used a
Differential cell counts from bronchoalveolar lavage Figure 5
Differential cell counts from bronchoalveolar lavage. 
Differential cell counts from the bronchoalveolar lavage 
(BAL) of naïve BALB/c mice, mice systemically sensitised and 
challenge with 1,3 or 6 OVA aerosols and mice systemically 
sensitized with OVA and challenged with a single PBS aero-
sol. BALs were collected 24 and 48 hours after the last aero-
sol. Data are expressed as mean ± SEM (n = 5–6). There was 
a significant increase in the number of eosinophils (p = 0.032) 
in the BAL following a single OVA aerosol. Exposure to 3 or 
more OVA aerosols caused a further increase in the number 
eosinophils (p < 0.001), compared to 1 OVA aerosol, and an 
increase in the number of macrophages (p < 0.001) com-
pared to naïve mice. There were neutrophils present in the 
BALs of some mice but only in those groups sensitised and 
challenged with OVA and only in BALs sampled 24 hours 
after the last aerosol.
Total serum IgE obtained from time resolved fluorescence Figure 6
Total serum IgE obtained from time resolved fluo-
rescence. Total IgE obtained from time resolved fluores-
cence assay of serum collected from systemically sensitised 
(i.p. OVA/Alum on day 0 and day 14) but not challenged with 
aerosolised antigen (white bars). The vertical bars represent 
total serum IgE from mice sensitised and challenged with 
either 1, 3 or 6 OVA aerosols. Serum samples from these 
mice were collected 24 (grey bars) and 48 (black bars) hours 
after the last aerosol. Data are expressed as mean ± SEM (n 
= 10). Two intraperitoneal injections of OVA/Alum were suf-
ficient to induce increased levels total IgE by day 21 (p < 
0.001) compared to naïve mice. Exposure to OVA aerosol 
challenges did not cause a further increase in total IgE (p = 
0.842).Respiratory Research 2004, 5:15 http://respiratory-research.com/content/5/1/15
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forced oscillation technique to measure changes in lung
mechanics in OVA sensitised and challenged mice. The
fact that the response was confined to the tissues is of
interest as the aim of these models is to mimic the human
asthmatic condition, in which a significant portion of
reactivity of the lungs is localised in the conducting air-
ways ([19]). This work emphasises the importance of
measuring bronchoconstriction with physiological tech-
niques capable of compartmentalising responses within
the lungs. By varying the antigen dose at challenge we
have revealed a system with the potential to allow investi-
gation of transient or prolonged responsiveness to MCh
that is localised in the airways, tissues, or both. Further
investigation is needed in order to understand the mech-
anisms that are influencing the site of responsiveness.
Typically, most human studies measure MCh responsive-
ness in terms of sensitivity as they report the concentra-
tion of MCh required to produce a 20% fall in FEV1. We
have shown that it is possible to determine sensitivity to
inhaled MCh in mice and that only the airway
compartment shows heightened sensitivity following
allergic sensitisation and challenge. While increased max-
imal responses can be seen in both airway and parenchy-
mal compartments, depending on which model is used,
no increase in parenchymal sensitivity is seen with any of
the models we used. As such, these findings reinforce the
value of using lung function techniques that are capable
of assessing airway and parenchymal mechanics
separately.
Total serum IgE was significantly elevated following sys-
temic sensitisation but was not increased by aerosol chal-
lenge. There was, however, a tendency for total serum IgE
to decline by day 27 in mice that were systemically sensi-
tised but not challenged with OVA aerosols, compared to
mice additionally exposed to 6 OVA aerosols. It is possible
that if the study had been extended to include further
exposure to antigen over subsequent days, a difference
would have been detected between mice that were only
sensitised and mice that were sensitised and challenged.
Given that antigen specific IgE and other immunoglobu-
lin subtypes were not measured in this study, further work
is required to characterise the effect of dose of antigen at
challenge on the development of antibody responses to
OVA in mice.
The protocol used in the present study induced significant
eosinophilia after a single airway challenge. The degree of
eosinophilia increased with increasing number of airway
challenges. This finding is consistent with several previous
studies using similar protocols to induce allergic
inflammation in the lungs of mice ([20,29-31]). While
the level of activation of the eosinophils was not meas-
ured in the present study, the 61% eosinophilia found
after 6 OVA aerosols was much higher than those that are
typically found in human asthmatics ([32]). Given the sig-
nificant and prolonged parenchymal response to inhaled
methacholine following 6 OVA aerosols and the level of
eosinophilia present, it is likely that this model more
closely parallels an allergic alveolitis ([33]) than the air-
way inflammation commonly seen in humans.
In recent studies there has been some focus on the associ-
ation, or lack thereof, between indicators of systemic sen-
sitisation, such as the levels of serum antibodies, airway
inflammation and AHR ([34]). In a review of the role of
IgE in the induction of eosinophilic airway inflammation
and AHR, Hamelmann et al. ([35]) concluded that sys-
temic methods of sensitisation resulted in high levels of
IgE and eosinophilic airway inflammation in BALB/c
mice. In these models, AHR was determined to be
dependent on eosinophils but not IgE. However, the
results of our study, which uses a similar protocol to those
reviewed by Hamelmann et al. ([35]), show that the pres-
ence of eosinophils did not always coincide with an
increase in responsiveness to MCh. Three OVA aerosols
resulted in a significant eosinophilia after 24 hours but an
increase in the response to the maximum dose of MCh
was not evident until 48 hours post challenge. In contrast,
a single OVA challenge resulted in hyperresponsiveness to
MCh that had resolved by 48 hours while the levels of
eosinophils remained significantly elevated. The levels of
total serum IgE were equivalent across all challenge doses
suggesting that, while the presence of IgE may be neces-
sary to initiate the allergic response, its presence at a par-
ticular measurement time point does not necessarily
relate to the presence of hyperresponsivenss.
Conclusions
The findings of the present study demonstrate the signifi-
cant impact of changing antigen challenge dose in a
murine model of allergic bronchopulmonary inflamma-
tion. Given the variability of the inflammatory profile and
characteristic responses observed in this study, it is clear
that investigators must carefully characterise their aller-
gen-driven murine models to ensure the model used con-
tains the characteristic of interest. Future studies need to
be directed at understanding the mechanisms that under-
lie airway and parenchymal hyperresponsiveness post
antigen challenge.
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